Resistance patterns of lower respiratory tract pathogens in Europe

International Journal of Antimicrobial Agents

Volumn 16, Issue SUPPL. 1, 2000, Pages 25-29

  Marchese, A ^a   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Europe; Haemophilus influenzae; Respiratory tract

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUSTRIA; BELGIUM; CONFERENCE PAPER; CZECH REPUBLIC; EUROPE; FRANCE; HAEMOPHILUS INFLUENZAE; HUNGARY; ITALY; LOWER RESPIRATORY TRACT; MORAXELLA CATARRHALIS; NETHERLANDS; NONHUMAN; POLAND; PRIORITY JOURNAL; SPAIN;

EID: 0034533592     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-8579(00)00302-2     Document Type: Conference Paper

References (32)

1. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally
2. Community-acquired pneumonia in adults: Guidelines for management
3. Trends in the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
4. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens. Findings of the Alexander Project 1992-1996
5. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
6. Antibiotic resistance in Streptococcus pneumoniae
7. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
8. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over-5 years period of decreased macrolide susceptibility rates
9. MLS resistance phenotypes and mechanisms in S. pneumoniae
10. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in Streptococcus pneumoniae
11. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicentre antibiotic resistance surveillance study conducted in the United States in 1994-1995
12. Epidemiology and mechanism of resistance among respiratory tract pathogens
13. Upper respiratory tract infections: Etiology, current treatment and experience with fluoroquinolones
14. Lower respiratory tract infections: Etiology, current treatment and experience with fluoroquinolones
15. Gram positive pneumonia
16. Isolation of an ampicillin-resistant, non beta-lactamase-producing strain of H. influenzae
17. Susceptibility of bacterial respiratory pathogens to amoxycillin and amoxycillin-clavulanic acid
18. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgeneus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. liquiefaciens and M. lacunata
19. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type enzyme but little permeability barrier to ampicillin
20. Determination of antimicrobial susceptibility of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases
21. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis
22. Haemophilus influenzae type B resistant to ampicillin. A report of two cases
23. Osservatorio epidemiologico italiano: Analisi del 2° anno di monitoraggio delle resistenze agli antibiotici in M. catarrhalis
24. Osservatorio epidemiologico Italiano: Introduzione, metodi e scopo della ricerca
25. Failure of treatment of pneumonia associated with highly resistant pneumococci in a child
26. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence
27. The role of quinolones in chronic obstructive pulmonary disease
28. Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal
29. In vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci
30. Oxazolidinones: A new class of antimicrobials